Pharmaceutical Sales Jobs – A USA Listing
|
Here’s the easiest way to get a job. Click Here |
|
|
|
|
|
IntellegoJobs Most Recent Tweets on Twitter – Job Opportunities and US Employment News Jobs for the Bookkeeper, CPA, Programmer, Computer Hardware Engineer, Computer Support Specialist, Civil Engineer, High School Teacher, Mechanical Engineer, Middle School Teacher, Pharma Sales Rep, Physician Assistant, Physical Therapy Assistant, Pilot, Registered Nurse, Sales Rep, Software Engineer, Systems Analyst, and Truck Driver |
Welcome to our Pharmaceutical Sales Jobs site. The purpose of this site is to provide a frequently updated list of current open positions for the pharmaceutical sales representative. Our focus is on pharmaceutical sales jobs which are available in the United States.
Our list of pharmaceutical sales jobs consists of a page for each state, and each page combines the results from several job search engines. Our paradigm is similar to the meta-search engines like Dogpile, except here we combine the results from job search engines as opposed to regular search engines.
Here we also provide to the pharmaceutical sales representative informative articles, useful statistics, videos, a selection of books, and current pharmaceutical industry news. The pharmaceutical sales jobs listed here are in the form of RSS feeds, and will be automatically updated when new jobs become available. This site is produced by IntellegoJobs, a division of Intellego Web Publishing.
The following data should be interesting to the pharmaceutical sales rep who resides within the United States. This data comes from the Bureau of Labor Statistics.
Sales Representatives for Technical and Scientific Products – Statistics (Bureau of Labor Statistics)
States with the highest concentration of sales representatives for technical and scientific products with annual salary:
(highest at top)
New Hampshire $77,120
Massachusetts $88,550
Utah $74,800
South Dakota $63,310
Arizona $61,560
Top paying states for sales representatives for technical and scientific products with annual salary:
(highest at top)
Delaware $91,220
Massachusetts $88,550
Maryland $85,790
Minnesota $85,090
District of Columbia $85,050
Mean annual salary for sales representatives for technical and scientific products:
$76,460
Metropolitan areas with the highest concentration of sales representatives for technical and scientific products with annual salary:
Nashua, NH-MA NECTA Division $78,780
Framingham, MA NECTA Division $74,970
Lowell-Billerica-Chelmsford, MA-NH NECTA Division $99,010
San Jose-Sunnyvale-Santa Clara, CA $100,000
Lake County-Kenosha County, IL-WI Metropolitan Division $88,440
Top paying metropolitan areas for sales representatives for technical and scientific products:
Sacramento—Arden-Arcade—Roseville, CA $102,360
San Jose-Sunnyvale-Santa Clara, CA $100,000
Lowell-Billerica-Chelmsford, MA-NH NECTA Division $99,010
Bridgeport-Stamford-Norwalk, CT $98,520
Wenatchee, WA $98,100
Industries with the highest level of employment for the sales representatives for technical and scientific products:
(highest at top)
Professional and Commercial Equipment and Supplies Merchant Wholesalers
Wholesale Electronic Markets and Agents and Brokers
Drugs and Druggists’ Sundries Merchant Wholesalers
Electrical and Electronic Goods Merchant Wholesalers
Computer Systems Design and Related Services
Top paying industries for sales representatives for technical and scientific products
Satellite Telecommunications $107,050
Other Professional, Scientific, and Technical Services $102,100
Other Motor Vehicle Dealers $97,980
Other Telecommunications $92,770
Computer and Peripheral Equipment Manufacturing $91,080
Training and requirements needed for the sales representatives for technical and scientific products:
Today, more frequently then not, employers are hiring sales representatives with a college degree, regardless of the type of product you are selling. If you want to be a pharmaceutical sales representative, indeed you should have a college degree. As a matter of fact, in most cases, you need a college degree if you want to sell any technical or scientific product.
The usual characteristics of any successful salesman such as a friendly personality, the ability to sell, and familiarity with the brand are also looked for in the pharmaceutical sales representative. Also, more so then many other sales positions, you need to sell the product to the physician within a very short period of time, usually a matter of minutes. This is simply because most doctors do not not have the time to listen to a long sales pitch.
In the pharmaceutical industry, it is essential that the sales rep have a complete and thorough knowledge of the drug he or she is selling. This includes side effects, interactions, efficacy, clinical trial data and more. Therefore extensive knowledge from the disciplines of chemistry and human biology are essential, along with a thirst for learning and understanding. Knowledge about drugs and medicines is also picked up from seminars and on the job training.
For more information about training required for the pharmaceutical sales representative in the United States go to Occupational Outlook Handbook provided by the Bureau of Labor Statistics.
Pharmaceutical Sales Jobs – Employment Growth and Outlook
Overall, sales employment growth in the United States is expected to be about average. Employment growth is expected to be around 9% between 2006 and 2016, which is average relative to all other occupations. It should be noted that this is for all sales positions.
As the elderly population in the United States continues to grow in size, their need for various medicines will also continue to grow. Drug companies will need to produce medicines with a high level of efficacy and fewer side effects in order to meet the medical needs of an increasing elderly population. Because the pharmaceutical sales representative is the interfacing pipeline between the drug company and the physician, this type of sales representative should continue to see increasing employment opportunities. Therefore, employment growth for the pharmaceutical sales representative should be greater then that which is expected for other sales positions.
It should also be noted that competition for technical and scientific product sales positions will be keen, including pharmaceutical sales representatives. This is because of the higher salary offered to individuals who hold these positions.
Source for the above data:
Bureau of Labor Statistics
Instantly post your resume to over 75 career sites. Click Here
E-Mail your Resume and Cover Letter to 1000’s of Headhunters, Click Here
Pharmaceutical Sales Jobs – Listed by State – Updated Daily
Informative Videos About How to Write the Resume
Pharmaceutical Industry News
Pharma Industry / Biotech Industry News From Medical News Today
Copyright 2012 Medical News Today
Latest Health News and Medical News posted throughout the day, every day.
Shortages Of Anti-Infective Drugs Pose Threat To Public Health And Patient Care
Shortages of key drugs used to fight infections represent a public health emergency and can put patients at risk, according to a review published in Clinical Infectious Diseases and available online*...
2nd Annual World Orphan Drug Congress USA, April 10-13 2012
Orphan drug development has become more feasible than in previous years but we've barely scratched the surface: only 367 approved orphan drugs out of 6,800 rare diseases. We need to keep the momentum going. Come April 10-13, over 300 key decision makers from orphan drug manufacturers, patient groups, payers and regulators will gather in DC at the 2nd annual World Orphan Drug Congress USA...
Seminar On Monitoring And Validating Pharmaceutical Water Systems, 22-23 February 2012, San Francisco, CA
ComplianceOnline, the leading governance, risk and compliance advisory network with over 500 experts in various regulatory subjects, today announced a seminar on The A to Z's of Microbial Control, Monitoring and Validation of Pharmaceutical Water Systems. The two day long, in-person seminar, led by well known water systems expert T.C...
Oxygen And Light Utilized In The Synthesis Of Anti-Malaria Drug
The most effective anti-malaria drug can now be produced inexpensively and in large quantities. This means that it will be possible to provide medication for the 225 million malaria patients in developing countries at an affordable price...
Clinical Outsourcing World Europe 2012, 7-8 February, Earls Court Conference Centre - London
Driving development through strategic outsourcingRegister NOW for the Clinical Outsourcing World conference to hear from the industry's BEST Outsourcing professionals including representatives from: GSK, Pfizer, AstraZeneca, Eli Lilly, Novartis, Almirall, Merck Research Laboratories and many more! Pharma & Biotech delegates- register NOW for only £250+vat! Please note this ...
Fake Antimalarial Medications Undermine Africa Malaria Drive
Fraudulent and substandard antimalarial drugs could be wrecking the chances of winning the war against malaria in Africa, researchers from the Wellcome Trust-Mahosot Hospital-Oxford University Tropical Medicine Research Collaboration reported in the Malaria Journal...
Blocking Cell-To-Cell Communication May Prevent Liver Damage And Improve Drug Safety
Massachusetts General Hospital (MGH) investigators have developed a novel strategy to protect the liver from drug-induced injury and improve associated drug safety...
Advances And Progress In Drug Design - Discover The Latest Developments 20-21 February 2012, Copthorne Tara Hotel, London
The number of pharmaceutical products entering the market has declined in the last decade. With the economic downturn and increasing threat from generic companies, pharmaceutical companies have never been under greater pressure to develop new innovative drugs...
Understand The Strategies And Developments In Pharmaceutical Parallel Trade, 6-7 February 2012 At The Copthorne Tara Hotel In London
SMi is proud to present their 6th annual Pharmaceutical Parallel Trade Conference, taking place on 6th & 7th February 2012 at the Copthorne Tara Hotel in London. This year's event will bring together expert speakers from different sectors within the industry, each with differing opinions and perspectives to offer...
Chemical Reaction Devized That Holds Promise For New Drug Development
A team of researchers at the California Institute of Technology (Caltech) has devised a new method for making complex molecules...
Major Advance In Understanding The Regulation Of An Important Cancer Target
Scientists at the University of Leicester have opened up a whole new approach to the therapeutic intervention for a family of anti-cancer drug targets, thanks to a completely new and unexpected finding...
Novartis' Troubles With Packaging Continue
Novartis Consumer Health announced earlier today a recall on certain OTC medicines that were badly packaged and might have broken or chipped pills, as well as incorrect product mixed into bottles of pills. Rather worrying for consumers with risks of possible wrong or overdoses of their medicine...
Novartis Recalls OTC Products Excedrin And NoDoz
Complaints of chipped and broken pills as well as inconsistent packaging have promoted Novartis Consumer Health Inc. (NCH) to recall certain lots of its products. Whilst there have been no reports of adverse effects to patients so far, Novartis has also warned of possible mixing of product. They have asked consumers to dispose of the product or return unused bottles...
New Drug Screening Identifies Chemical Agents With Potent Anti-Cancer Activity
Drugs already approved for clinical use across a variety of therapeutic categories can be screened to identify effective agents for thyroid cancer according to a recent study accepted for publication in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). These findings could rapidly be implemented into a clinical trial to test how effective the treatment would be...
The Importance Of Compliance In Your KOL Interactions
With the recent changes to regulations about interactions with external stakeholders, it can be hard to keep up to date. Eyeforpharma spoke to Julian Jenkins, Head of Global Medical Affairs at Ferring Pharmaceuticals about how to work compliantly under the changing regulatory environment...
Discovery Of One Of The Most Porous Materials To Date Will Improve Control In Drug Delivery
The delivery of pharmaceuticals into the human body or the storage of voluminous quantities of gas molecules could now be better controlled, thanks to a study by University of Pittsburgh researchers. In a paper published online in Nature Communications, a team of chemists and colleagues from Pitt's Kenneth P...
ONSOLIS To Benefit From Approval Of Class-Wide REMS For All Transmucosal Fentanyl Products
BioDelivery Sciences International, Inc. (Nasdaq: BDSI) responded to the approval and announcement by the U.S. Food and Drug Administration (FDA) that a Risk Evaluation Mitigation Strategy (REMS) covering all transmucosal fentanyl products has been approved...
FDA Approves Shared REMS (Risk Evaluation And Mitigation Strategy) Program For All TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments
ProStrakan, Inc., a subsidiary of Kyowa Hakko Kirin Co. Ltd. (KHK), and an international specialty pharmaceutical company, announces that the U.S. Food and Drug Administration (FDA) has approved the TIRF (Transmucosal Immediate Release Fentanyl) REMS (Risk Evaluation and Mitigation Strategy) Access program...
Marinus Pharmaceuticals Experimental Epilepsy Treatment Shows Promise In Open-Label Extension Study
Marinus Pharmaceuticals, Inc., a specialty pharmaceutical company, announced that its neurosteroid ganaxolone which is currently under study for the treatment of partial onset seizures (POS), reported positive data in the open-label extension follow up to the company's Phase 2 clinical trial. The data reflects the replication of the effects seen in the double-blind study...
VIVUS Announces Date Of FDA Advisory Committee Review Of Qnexa For The Treatment Of Obesity
VIVUS, Inc. (NASDAQ: VVUS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is scheduled to review the Company's New Drug Application (NDA) for Qnexa for the treatment of obesity on February 22, 2012. VIVUS resubmitted the NDA on October 17, 2011 seeking approval to market Qnexa in the United States...
Taking A Predictive Approach To Identifying Adverse Drug Reactions
In a move aimed at bolstering current systems for assessing and monitoring drug safety, researchers at Children's Hospital Boston have created a new method that combines multiple forms of widely available data to predict adverse drug reactions...
Jennerex Announces First Patient Treated In Phase 2a Clinical Trial Of JX-594 As A Neoadjuvant Therapy In Colorectal Cancer
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, announced that the first patient has been treated in a Phase 2a clinical trial of JX-594 as a neoadjuvant therapy in patients who are undergoing surgery to treat colorectal cancer that has spread to the liver...
FDA To Review Potential New Use Of XGEVA® (Denosumab) At Oncologic Drugs Advisory Committee Meeting
Amgen (NASDAQ: AMGN) announced the U.S. Food and Drug Administration (FDA) has invited the Company to participate in a meeting of the Oncologic Drugs Advisory Committee (ODAC) on Feb. 8, 2012 to discuss the supplemental Biologics License Application (sBLA) for XGEVA® (denosumab) to treat men with castration-resistant prostate cancer (CRPC) at high risk of developing bone metastases...
"Science" Names HIV Prevention Trial As Breakthrough Of The Year
Science named the HIV Prevention Trials Network (HPTN) 052 study "Breakthrough of the Year." FHI 360 congratulates our HPTN 052 collaborating partners on this important achievement. This is the second year in a row that Science selected a trial for which FHI 360 provided scientific leadership and operational support...
Denali Concrete Management Inc. Announces The Commencement Of Patient Enrollment For The Phase 3 Dry Eye Syndrome Study
Denali Concrete Management Inc. (OTCBB: DCMG) announced that it has commenced patient enrollment for a phase 3 clinical study of the safety and efficacy of CF101, daily administered orally, in patients with moderate-to-severe Dry Eye Syndrome. This multi-center clinical trial is conducted in the United States, Europe and Israel...
Pharma Marketing Blog
Allergan "Badly Let Down" by Employee Tweet
Taking the "Cool" Way Out of Having Rx Product Convos on Social Media
Should Pharma Disclose Payments to Celebrity Spokespeople?
Did FDA Entrap Google with Those 14 NOV Letters?
Is There a Cure for Mediocre Pharma Mobile Apps?
Three Companies Compete for Diabetes Market Share Using Recipes Rather Than Product Efficacy
Novo Nordisk Defends Choice of Paula Deen Over Anthony Bourdain (for example) as Celebrity Chef Spokesperson
Pfizer & PhRMA Lobby in Support of SOPA
My Bad! Paula Dean Shills for Novo Nordisk, Not Novartis
Sanofi vs Novartis: Paul Sorvino vs. Paula Deen
Are You Part of My Social Media Mosaic?
FDA Sends Warning Letter to Website to Cease & Desist: It Doesn't
Despite Increase in DTC Ad Spending, WebMD Suffers
FDA's Advisory Committee Voting Double Standard
Thera Max YouTube Video "Social Media Strategy" Makes Americans Look Like Fools!
Lilly Sales Reps Learn Marketing Lessons From Disney's Animal Keepers
Predicting the Future of the Drug Industry: 2012 and Beyond
Games vs. Mobile Health Monitoring Devices: Which is a Better Motivator?
FDA Social Media Guidelines May Be Moot If This Court Decision Holds Up
2011 in Images from Pharma Marketing Blog
FDA Guidance on Responding to Unsolicited Requests for Off-Label Information Via Social Media
Webicina's "Open Access" Social Media Guidelines for Pharma
Proposed Rules for Physician Payment Sunshine Act: Some Clouds on the Horizon
Pharmaceutical Representative Magazine Closes. Blame CafePharma!
Crestor Grapples to Compete with Lipitor: #Fail!
7r5wk2sayt
Powered by FirstRSS Plugin
